Oncology Central

What if you had a new exam that could help you give your patients a quick and confident diagnosis in breast cancer care?


Performed as an adjunct to inconclusive mammography and ultrasound, SenoBright contrast enhanced spectral mammography (CESM) highlights areas of unusual blood flow patterns that may be cause for increased suspicion – all in a simple, quick, procedure.

GE Healthcare introduces the contrast enhanced spectral mammography exam. With SenoBright, you can give your patients a confident diagnosis the same day, in the same place, in less than 7 minutes after the inconclusive mammogram. SenoBright helps you to reduce false positives and helps prevent unnecessary biopsies and surgeries.





News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.